Browsing by Author "Lee, P. C."

Now showing 1 - 2 of 2

Computation of brain neurodegeneration in the Alzheimer's fly
(2006-01-01)
Lee, P. C.
;
Huang, Y. R.
;
Chang, H. M.
;
Chiang, A. S.
;
Ching, Y. T.
Expression of human A beta 42 peptide in the Drosophila brain induces pathological phenotypes resembling Alzheimer's disease (PNAS 101, 6623-6628). Three-dimensional confocal imaging reveals extensive vacuoles caused by neurodegeneration in the brain of aged but not young A beta 42 flies. Here, we report a three-dimensional computation algorisin allowing semi-automatic measurement of numbers and volumes of brain vacuoles. The method employed matched filters, alpha-shape, and the active-contour techniques. Using this method, a good result depicting the contours of the vacuoles can be obtained. A more accurate algorithm is still under development. Accurate evaluation of brain pathology in Alzheimer's flies may facilitate the understanding of molecular mechanisms underlying A beta. toxicity and the discovery of novel therapeutic targets for Alzheimer's disease.
Computation of brain neurodegeneration in the Alzheimer's fly - art. no. 61433E
(2006)
Lee, P. C.
;
Huang, Y. R.
;
Chang, H. M.
;
Chiang, A. S.
;
Ching, Y. T.
Expression of human A beta 42 peptide in the Drosophila brain induces pathological phenotypes resembling Alzheimer's disease (PNAS 101, 6623-6628). Three-dimensional confocal imaging reveals extensive vacuoles caused by neurodegeneration in the brain of aged but not young A beta 42 flies. Here, we report a three-dimensional computation algorisin allowing semi-automatic measurement of numbers and volumes of brain vacuoles. The method employed matched filters, alpha-shape, and the active-contour techniques. Using this method, a good result depicting the contours of the vacuoles can be obtained. A more accurate algorithm is still under development. Accurate evaluation of brain pathology in Alzheimer's flies may facilitate the understanding of molecular mechanisms underlying A beta. toxicity and the discovery of novel therapeutic targets for Alzheimer's disease.